
    
      Evaluate the antidepressant effectiveness of acute treatment with NeuroStar TMS Therapy in
      patients with MDD with postpartum onset.

      Determine the safety of NeuroStar TMS Therapy by assessment of any medically significant,
      device-related adverse events during acute treatment.

      Determine the Safety of NeuroStar TMS Therapy by assessment of maternal and infant
      interactions on standardized bonding questionnaires.
    
  